Predicting Risk of Pulmonary Fibrosis Formation in PASC Patients
While the acute phase of the COVID-19 pandemic has subsided, its long-term effects persist through Post-Acute Sequelae of COVID-19 (PASC), commonly known as Long COVID. There remains substantial uncertainty regarding both its duration and optimal management strategies. PASC manifests as a diverse array of persistent or newly emerging symptoms--ranging from fatigue, dyspnea, and neurologic impairments (e.g., brain fog), to cardiovascular, pulmonary, and musculoskeletal abnormalities--that extend beyond the acute infection phase. This heterogeneous presentation poses substantial challenges for clinical assessment, diagnosis, and treatment planning. In this paper, we focus on imaging findings that may suggest fibrotic damage in the lungs, a critical manifestation characterized by scarring of lung tissue, which can potentially affect long-term respiratory function in patients with PASC. This study introduces a novel multi-center chest CT analysis framework that combines deep learning and radiomics for fibrosis prediction. Our approach leverages convolutional neural networks (CNNs) and interpretable feature extraction, achieving 82.2% accuracy and 85.5% AUC in classification tasks. We demonstrate the effectiveness of Grad-CAM visualization and radiomics-based feature analysis in providing clinically relevant insights for PASC-related lung fibrosis prediction. Our findings highlight the potential of deep learning-driven computational methods for early detection and risk assessment of PASC-related lung fibrosis--presented for the first time in the literature.
Code (0)
등록된 구현이 없습니다.
Methods 이 논문이 사용한 방법론
Similar Papers 제목 키워드 기반
Fibrosis-Net: A Tailored Deep Convolutional Neural Network Design for Prediction of Pulmonary Fibrosis Progression from Chest CT Images
Pulmonary fibrosis is a devastating chronic lung disease that causes irreparable lung tissue scarring and damage, resulting in progressive loss in lung capacity and has no known cure. A critical step in the treatment and…
Computed Tomography (CT)Decision MakingManagementPrognostic Model for Idiopathic Pulmonary Fibrosis Using Context-Aware Sequential-Parallel Hybrid Transformer and Enriched Clinical Information
Idiopathic pulmonary fibrosis (IPF) is a progressive disease that irreversibly transforms lung tissue into rigid fibrotic structures, leading to debilitating symptoms such as shortness of breath and chronic fatigue. The …
DiagnosticCharacterizing Pulmonary Fibrosis Patterns in Post-COVID-19 Patients through Machine Learning Algorithms
The COVID-19 pandemic has left a lasting impact on global healthcare systems, with increasing evidence of pulmonary fibrosis emerging as a post-infection complication. This study presents a comprehensive analysis of pulm…
Decision MakingFibro-CoSANet: Pulmonary Fibrosis Prognosis Prediction using a Convolutional Self Attention Network
Idiopathic pulmonary fibrosis (IPF) is a restrictive interstitial lung disease that causes lung function decline by lung tissue scarring. Although lung function decline is assessed by the forced vital capacity (FVC), det…
PrognosisFibroVit—Vision transformer-based framework for detection and classification of pulmonary fibrosis from chest CT images
Pulmonary Fibrosis (PF) is an immedicable respiratory condition distinguished by permanent fibrotic alterations in the pulmonary tissue for which there is no cure. Hence, it is crucial to diagnose PF swiftly and precisel…
DiagnosticSpecificity